Leukemia Medical Procedures: What to Expect at Each Step

·

Share

The main leukemia medical procedures are blood tests (a complete blood count and blood smear), a bone marrow aspiration and biopsy, specialized lab tests on those samples (flow cytometry, chromosome and gene testing), sometimes a lumbar puncture or imaging, and the procedures used during treatment, such as central line placement, transfusions, and stem cell transplantation. Each has a specific job: confirming leukemia, identifying its exact type, and delivering or monitoring treatment.

In hematology, these procedures are the foundation of good care. Patients and students often ask me what each one involves, whether it hurts, and what the results mean. This guide answers those questions step by step.

Which Procedures Are Used in Leukemia?

Procedures fall into two broad groups: those that diagnose and classify leukemia, and those that support treatment. The table below summarizes the most common ones.

Procedure Purpose What it involves
Complete blood count (CBC) and smear First screen for abnormal counts and blast cells A routine blood draw from the arm
Bone marrow aspiration and biopsy Confirms diagnosis and extent of disease Needle sample from the back of the hip bone under local anesthetic
Flow cytometry Identifies the leukemia type from cell-surface markers Lab test on blood or marrow
Cytogenetics and molecular testing Finds chromosome changes and mutations that guide therapy Lab test on blood or marrow
Lumbar puncture Checks for leukemia in the spinal fluid; may deliver chemotherapy Thin needle into the lower back
Imaging (X-ray, ultrasound, CT) Looks at lymph nodes, spleen, chest, or infection Non-invasive scans
Central venous catheter Allows repeated chemotherapy, transfusions, and blood draws A line placed into a large vein in the chest or arm

Who Needs These Procedures?

Testing usually starts when someone has symptoms that suggest a blood problem, or when a routine blood test is abnormal. Common reasons include persistent fatigue, unexplained fever, frequent infections, easy bruising or bleeding, and swollen lymph nodes.

  • CBC: the first test for almost everyone. It may show a high or low white cell count, anemia, or low platelets. Normal adult platelets are 150,000–450,000 per microliter, and normal white cells are about 4,000–11,000 per microliter.
  • Bone marrow biopsy: indicated when the blood test suggests leukemia or when counts are unexplained.
  • Flow cytometry: used to classify leukemia by analyzing markers on cell surfaces.
  • Lumbar puncture: routine in acute lymphoblastic leukemia and in some other situations where the brain or spinal fluid may be involved.

In my clinic, unexplained abnormalities in more than one blood cell line are the most common reason I arrange a marrow examination.

How to Prepare

Preparation depends on the procedure. A blood test usually needs no preparation at all. Invasive procedures need a little more planning.

General preparation

  • Tell your team about all medicines, especially blood thinners, antiplatelet drugs, and supplements that affect bleeding.
  • Mention allergies, particularly to local anesthetics, latex, or antiseptics, and any past reactions to sedation.
  • Your platelet count and clotting tests may be checked beforehand, and a platelet transfusion given if the count is very low.

Procedure-specific tips

  • Bone marrow biopsy: if you will receive sedation, you may be asked not to eat for a few hours, and you should arrange for someone to drive you home.
  • Imaging: some CT scans need a short fast or contrast dye; your team will give specific instructions.
  • Lumbar puncture: wear comfortable clothing and plan to rest afterwards.

What Happens During the Procedures

A CBC is a simple blood draw that takes a few minutes. A bone marrow examination is more involved but is usually done as an outpatient procedure and takes about 20 to 30 minutes in total.

Bone marrow is the soft tissue inside bones where blood cells are made. To sample it, you usually lie on your side or front. The skin over the back of the hip bone is cleaned and numbed with local anesthetic. A needle is passed into the bone to draw out liquid marrow (the aspirate), and a second, slightly larger needle removes a small core of bone (the trephine biopsy).

Most people feel pressure and a brief, sharp pulling sensation when the liquid is drawn. Local anesthesia numbs the skin and bone surface well, and some centers offer light sedation.

A lumbar puncture is done with you curled on your side or sitting forward. After local anesthetic, a fine needle is placed between the lower spinal bones to collect a small amount of fluid. The samples from all these procedures are then processed in the laboratory for microscopy, flow cytometry, and genetic tests.

Recovery, Aftercare, and Risks

Recovery is usually quick. After a blood test, there is no downtime. After a marrow biopsy, most people go home the same day with a small dressing and mild soreness for a few days.

Aftercare instructions

  • Keep the biopsy site clean and dry, usually for about 24 hours.
  • Avoid strenuous activity for a day or so.
  • Simple pain relief is often enough; ask which medicines are safe with your platelet count.
  • If you had sedation, do not drive or operate machinery for 24 hours.
  • After a lumbar puncture, rest and drink fluids; a headache that is worse when upright should be reported.

Possible complications

These procedures are generally safe. The most common problems are bruising, minor bleeding, and soreness at the site. Infection is uncommon when sterile technique is used. Rarely, people react to anesthetic or sedation. Contact your care team if you notice bleeding that does not stop with pressure, spreading redness, fever, or pain that keeps increasing.

Understanding Your Results

Results are released in stages. The blood count is available within hours, and an initial look at the marrow often comes within a day or two. Flow cytometry usually follows soon after, while chromosome and mutation results can take one to several weeks.

These results confirm the diagnosis, define the subtype, place the leukemia in a risk group, and set the baseline for measuring response. Later, repeat marrow tests and sensitive tests for measurable residual disease show how well treatment is working. Your hematologist will explain how the results fit together and what they mean for leukemia treatment decisions. For an overview of the disease itself, see our leukemia guide.

Key Takeaways

  • A CBC is the first step; a bone marrow aspiration and biopsy usually confirms the diagnosis.
  • Flow cytometry and genetic tests on the samples identify the exact leukemia type and guide therapy.
  • Most procedures are done as outpatients under local anesthetic, with brief recovery.
  • Tell your team about blood thinners and allergies beforehand, and follow aftercare advice closely.
  • Report fever, persistent bleeding, or worsening pain after any procedure.

Frequently Asked Questions

Does a bone marrow biopsy hurt?

Most people describe pressure and a short, sharp ache when the liquid marrow is drawn, lasting a few seconds. Local anesthetic numbs the skin and bone surface, and sedation is available in many centers. Soreness afterwards is usually mild and settles within a few days.

How long does it take to get leukemia test results?

Blood counts come back within hours, and preliminary marrow findings often within a day or two. Detailed genetic results may take one to several weeks. In urgent cases, treatment can begin before every result is back.

Will I need repeat procedures during treatment?

Yes, usually. Blood counts are checked frequently, and repeat marrow examinations are commonly done at set points to measure response. People with certain leukemias may also need several lumbar punctures to deliver treatment into the spinal fluid.

Can I go home the same day after a bone marrow biopsy?

In most cases, yes. You will typically rest briefly while the site is checked for bleeding. If you had sedation, someone will need to take you home.

Written by
Haematology, Leukaemia, Oncology
Contact [email protected] Website Oregon Health & Science University May 11, 2020 Targeting signaling and epigenetic dysfunction in CSF3R-driven leukemias Research in my laboratory is centered on uncovering the biochemical, signaling, and epigenetic defects that drive myeloid disorders. Our long-term goal is to harness this mechanistic understanding to facilitate the development of better treatments for patients. Our group is part of…
View Full Profile →
Web Admin Avatar